Categories: impact investment

8 March 2022 15:27

Pharem welcomes Jula Holding as new owner

Pharem welcomes Jula Holding as owner in the ongoing series A financing round. Jula Miljö & Energi, a part of Jula Holding, takes a substantial lead position and aims to close the round in the coming months.

Pharem brands the PFS technology to Zymatic and presents a flexible water treatment technology to the market.

1 April 2021 14:10

Pharem launches the Zymatic brand after completing the Horizon EU 2020 project

The Horizon 2020 project (called PFS), which represented Pharem's wastewater treatment technology, has been completed with all important objectives achieved. The project demonstrated the capacity of the enzyme treatment technology under operating conditions at wastewater treatment plants (WWTPs) as well as its ability to remove a wide range of pharmaceutical residues found in effluent wastewater.

Passion for Water Sustainability

Pharem is specialized in enzymatic treatment of wastewater to remove organic micro-pollutants.

We use our broad biotechnology expertise to develop innovative enzymatic products which provide an effective means of removing organic pollutants in water environments. Our products are specifically developed to meet client needs for simple, effective solutions to tackle serious environmental issues within their operational scope.

Through close, ongoing collaboration with stakeholders, we are constantly working toward meeting customer’s requirements and exceeding expectations by providing safe, innovative, and cost-efficient products to counteract the impact organic pollutants have on the environment.